Intuitive Surgical, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Intuitive Surgical, Inc. (ISRG) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-07-21
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.00.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $229.86, a 20.88% decline year-over-year.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $0.00.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $267.38, a 7.11% increase from fiscal 2022.
- Intuitive Surgical, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $249.62, a 15.25% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-21 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-04-22 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-02-03 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-10-22 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-07-23 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-04-23 | |||
| 2024-12-31 | $0.00 10-K · filed 2025-01-31 | |||
| 2024-09-30 | $0.00 10-Q · filed 2024-10-18 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-07-19 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-04-19 | |||
| 2023-12-31 | $267.38 10-K · filed 2024-01-31 | |||
| 2023-09-30 | $267.32 10-Q · filed 2023-10-20 | |||
| 2023-06-30 | $233.50 10-Q · filed 2023-07-24 | |||
| 2023-03-31 | $229.86 10-Q · filed 2023-04-20 | |||
| 2022-12-31 | $249.62 10-K · filed 2023-02-10 | |||
| 2022-09-30 | $250.26 10-Q · filed 2022-10-21 | |||
| 2022-06-30 | $287.28 10-Q · filed 2022-07-22 | |||
| 2022-03-31 | $290.51 10-Q · filed 2022-04-22 | |||
| 2021-12-31 | $294.53 10-K · filed 2022-02-03 | |||
| 2021-09-30 | $294.53 10-Q · filed 2021-10-20 | |||
| 2021-06-30 | $744.83 10-Q · filed 2021-07-21 | |||
| 2021-03-31 | $740.73 10-Q · filed 2021-04-21 | |||
| 2020-12-31 | $624.45 10-K · filed 2021-02-10 | |||
| 2020-09-30 | $619.59 10-Q · filed 2020-10-19 | |||
| 2020-06-30 | $537.87 10-Q · filed 2020-07-23 | |||
| 2020-03-31 | $539.01 10-Q · filed 2020-04-17 | |||
| 2019-12-31 | $523.30 10-K · filed 2020-02-07 | |||
| 2019-09-30 | $521.46 10-Q · filed 2019-10-18 | |||
| 2019-06-30 | $538.14 10-Q · filed 2019-07-22 | |||
| 2019-03-31 | $541.37 10-Q · filed 2019-04-19 | |||
| 2018-12-31 | $475.38 10-K · filed 2019-02-04 | |||
| 2018-09-30 | $470.83 10-Q · filed 2018-10-22 | |||
| 2018-06-30 | $422.16 10-Q · filed 2018-07-20 | |||
| 2018-03-31 | $417.56 10-Q · filed 2018-04-18 | |||
| 2017-12-31 | $287.11 10-K · filed 2018-02-02 | |||
| 2017-09-30 | $282.99 10-Q · filed 2017-10-20 | |||
| 2017-06-30 | $734.29 10-Q · filed 2017-07-21 | |||
| 2017-03-31 | $713.68 10-Q · filed 2017-04-19 | |||
| 2016-12-31 | $616.97 10-K · filed 2017-02-06 | |||
| 2016-09-30 | $614.59 10-Q · filed 2016-10-19 | |||
| 2016-06-30 | $546.44 10-Q · filed 2016-07-20 | |||
| 2016-03-31 | $536.61 10-Q · filed 2016-04-19 | |||
| 2015-12-31 | $519.41 10-K · filed 2016-02-02 | |||
| 2015-09-30 | $520.10 10-Q · filed 2015-10-21 | |||
| 2015-06-30 | $512.48 10-Q · filed 2015-07-22 | |||
| 2015-03-31 | $513.90 10-Q · filed 2015-04-22 | |||
| 2014-12-31 | $446.91 10-K · filed 2015-02-06 | |||
| 2014-09-30 | $445.03 10-Q · filed 2014-10-23 | |||
| 2014-06-30 | $435.91 10-Q · filed 2014-07-24 | |||
| 2014-03-31 | $440.40 10-Q · filed 2014-04-25 | |||
| 2013-12-31 | $471.33 10-K · filed 2014-02-03 | |||
| 2013-09-30 | $473.68 10-Q · filed 2013-10-18 | |||
| 2013-06-30 | $554.50 10-Q · filed 2013-07-22 | |||
| 2013-03-31 | $564.21 10-Q · filed 2013-04-19 | |||
| 2012-12-31 | $513.25 10-K · filed 2013-02-04 | |||
| 2012-09-30 | $512.50 10-Q · filed 2012-10-18 | |||
| 2012-06-30 | $508.70 10-Q · filed 2012-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |